Literature DB >> 3493206

Activation of B chronic lymphocytic leukaemia cells by Branhamella catarrhalis.

J E Calvert, S J Proctor, R Jefferis.   

Abstract

Cells from the blood of patients with chronic lymphocytic leukaemia were cultured in the presence of two polyclonal activators of human B cells, the bacteria Branhamella catarrhalis (Bc) and Staphylococcus aureus Cowan 1 (SAC). Although the magnitude of the responses varied, cells from seven of the eight patients studied were induced to proliferate in response to Bc. In contrast, the response to SAC was low or negligible in seven of the eight patients, and only one patient responded well to this mitogen. Bc was also effective in inducing secretion of IgM in cells from seven of the eight patients, and this was unaffected by removal of T cells. Fractionation of CLL cells on density gradients showed that the highest level of IgM production was induced in cells with a low buoyant density, whilst cells with a high buoyant density secreted little or no immunoglobulin in response to Bc. Together, these results demonstrate that Bc is an effective, T-independent activator of both DNA synthesis and immunoglobulin production in CLL cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493206      PMCID: PMC1453342     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia.

Authors:  S M Fu; N Chiorazzi; H G Kunkel
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Many bacterial species are mitogenic for human blood B lymphocytes.

Authors:  G Banck; A Forsgren
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

3.  Multiparameter studies in lymphoid leukemias.

Authors:  D Catovsky; S Pittman; M O'Brien; M Cherchi; C Costello; R Foa; E Pearce; A V Hoffbrand; G Janossy; K Ganeshaguru; M F Greaves
Journal:  Am J Clin Pathol       Date:  1979-10       Impact factor: 2.493

4.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

5.  Comparison of normal and CLL lymphocyte surface Ig determinants using peroxidase-labeled antibodies. I. Detection and quantitation of light chain determinants.

Authors:  T Ternynck; G Dighiero; J Follezou; J L Binet
Journal:  Blood       Date:  1974-06       Impact factor: 22.113

6.  Protein A reactivity of IgM- and IgD-bearing lymphocytes from some patients with chronic lymphocytic leukemia.

Authors:  S Romagnani; G M Giudizi; F Almerigogna; R Biagiotti; G Bellesi; F Bernardi; M Ricci
Journal:  Clin Immunol Immunopathol       Date:  1981-04

7.  Human B-lymphocyte subpopulations. I. Differentiation of density-separated B lymphocytes.

Authors:  M K Dagg; D Levitt
Journal:  Clin Immunol Immunopathol       Date:  1981-10

8.  Monoclonal gammopathy in lymphoma.

Authors:  R Alexanian
Journal:  Arch Intern Med       Date:  1975-01

9.  Mitogenic response of neoplastic B cells: comparison of reactivity to Staphylococcus aureus Cowan I and anti-immunoglobulin antibodies.

Authors:  T Tamaki; T Yonezawa; Y Kanakura; S Katagiri; H Mizutani; T Kitani; S Tarui
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

10.  Antigen-initiated B-lymphocyte differentiation. VIII. Sedimentation velocity and buoyant density characterization of virgin antibody-forming cell progenitors in the adoptive immune response of unprimed CBA mice to 4-hydroxy-3-iodo-5-nitrophenylacetic acid-polymerized bacterial flagellin antigen.

Authors:  J M Fidler; M C Howard; K Shortman
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  1 in total

1.  Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture.

Authors:  P Bird; J E Calvert; H Mitchison; N R Ling; M Bassendine; O F James
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.